Preclinical feasibility of EPID‐based transit dosimetry for total body irradiation
Journal of Applied Clinical Medical Physics · 2026
DOI: 10.1002/acm2.70790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2026. Verfasst von Tetsu Nakaichi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Section of Radiation Safety and Quality Assurance, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Phantoms, Imaging, Whole-Body Irradiation, Radiometry, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science, and Technology, National Cancer Center Research and Development Fund, Cancer Intelligence Care Systems, Inc..
Abstract (Originalsprache)
Background
Conventional extended‐distance total body irradiation (TBI) is commonly verified using point dosimeters, which provide limited spatial information and require additional handling during a prolonged treatment procedure. A portable charge‐coupled device (CCD)‐based electronic portal imaging device (EPID) positioned downstream of the patient may provide wider‐area transit information in a geometry in which a gantry‐mounted EPID cannot readily be used.
Purpose
To develop and perform preclinical phantom validation of a CCD‐EPID method for transit dose estimation during fixed‐field long‐SSD TBI and to identify the calibration and normalization factors relevant to subsequent patient validation.
Methods
A portable CCD‐based EPID was positioned at 400 cm, with water‐equivalent or anthropomorphic phantoms centered at 350 cm. Direct‐irradiation characteristics were evaluated for 4‐ and 10‐MV photon beams, including signal response to dose‐rate/delivered MU, field size, short‐term frame reproducibility, and in‐plane response. For ETD calibration, 6–36‐cm‐thick water‐equivalent phantoms were irradiated with 10‐MV photons using 1000 MU at 600 MU/min and a 10 × 10 cm 2 jaw setting at isocenter, corresponding to approximately 35 × 35 cm 2 at the phantom and 40 × 40 cm 2 at the EPID. Summed EPID signals were related to midplane absorbed dose measured using a Farmer‐type ionization chamber. ETD was independently compared with radiophotoluminescent dosimeters (RPLDs) in 12‐, 24‐, and 36‐cm slab phantoms and at 11 locations in a RANDO phantom. Four separate RANDO irradiations were centered on the head, chest, abdomen, and pelvis.
Results
The 10‐MV EPID signal was highly linear with dose rate/delivered MU ( r = .999) and field size ( r = .995). Flatness was 1.4% and 1.3%, and symmetry was .3% and 1.4%, in the ceiling‐floor and gun‐target directions, respectively. The summed EPID signal‐to‐ionization‐chamber dose relationship showed R 2 = .999. ETD differed from RPLD dose by −1.6%, −1.4%, and .0% in the 12‐, 24‐, and 36‐cm slab phantoms, respectively, within the expanded RPLD uncertainty. In the RANDO phantom, ETD was consistently higher than RPLD dose, with a mean relative difference of 7.7 ± 3.9%. Because calibration and RANDO verification used the same field size and the detector showed high dose/MU linearity, a field‐size mismatch or gross signal nonlinearity is unlikely to be the dominant explanation. Heterogeneous attenuation and scatter, local path‐length/ROI correspondence, and session‐dependent CCD sensitivity are plausible contributors.
Conclusions
This preclinical phantom study demonstrates the feasibility of wide‐area CCD‐EPID transit‐dose estimation for conventional long‐SSD TBI. Agreement in homogeneous phantoms supports the calibration approach, while the positive RANDO bias identifies the need for same‐day sensitivity normalization and further validation in repeated anthropomorphic, heterogeneous, lung‐shielded, and full‐clinical‐field conditions before patient application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Radiation Safety and Quality Assurance, National Cancer Center Hospital, Tokyo, Japan.
- Department of Radiology, Tokyo Medical Center, National Hospital Organization, Tokyo, Japan.
- Department of Radiological Technology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Radiation Oncology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
- Department of Radiological Science, Graduate School of Human Health Science, Tokyo Metropolitan University, Tokyo, Japan.
- Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.
Förderung
- Ministry of Education, Culture, Sports, Science, and Technology
- National Cancer Center Research and Development Fund
- Cancer Intelligence Care Systems, Inc.
Zitieren
APA
Nakaichi, T., Okamoto, H., Kon, M., Takaso, K., Aikawa, A., Nakamura, S., Iijima, K., Chiba, T., Nakayama, H., Goka, T., & Igaki, H. (2026). Preclinical feasibility of EPID‐based transit dosimetry for total body irradiation. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70790
Vancouver
Nakaichi T, Okamoto H, Kon M, Takaso K, Aikawa A, Nakamura S, et al. Preclinical feasibility of EPID‐based transit dosimetry for total body irradiation. Journal of Applied Clinical Medical Physics. 2026. doi:10.1002/acm2.70790
BibTeX
@article{Nakaichi2026,
author = {Nakaichi, Tetsu and Okamoto, Hiroyuki and Kon, Mitsuhiro and Takaso, Kazuki and Aikawa, Ako and Nakamura, Satoshi and Iijima, Kotaro and Chiba, Takahito and Nakayama, Hiroki and Goka, Tomonori and Igaki, Hiroshi},
title = {Preclinical feasibility of EPID‐based transit dosimetry for total body irradiation},
journal = {Journal of Applied Clinical Medical Physics},
year = {2026},
doi = {10.1002/acm2.70790}
}
EUVIMED